AI-MED SPIDER/PDD
Patient's Data De-Identifier
At AI-MED Trial, we prioritize the privacy and security of patient data in clinical trials. We understand the importance of maintaining trust and confidentiality, and we are committed to upholding the highest standards of data protection.
The primary objective of AI-MED SPIDER© /PDD is to facilitate the secure and compliant export / importation and management of anonymized patient data from various sources. This platform guarantees the privacy and anonymity of individual patient data, while enabling consistent and precise data aggregation across diverse databases.
According to the requirement for the removal of singularities, to qualify a data processing operation as anonymization and thus exempted from the strict regulations of the GDPR, the data will be processed in such a way that it is no longer possible to isolate or identify a single individual within the dataset. This means it should be impossible to trace the identity of a specific person, even using advanced correlation techniques or additional information.
Applications
Multi-Source Clinical Trials
Enables accurate combination of patient data from multiple sources while maintaining anonymity and protecting patient identity.
Data Integrations
Streamlines the merging of patient records from different databases into a cohesive, unified dataset.
Regulatory Compliance
Supports compliance with strict data privacy regulations, such as GDPR and HIPAA, ensuring secure and ethical data handling.
How it works
- Unique Identifier Creation. Each patient gets a unique, consistent identifier across all sites and databases for easy data integration.
- Security and Privacy. The identifier is non-reversible, meaning it can’t be traced back to the original patient data, with cryptographic protection in place.
- Tokenization. A secure, consistent token is used to ensure the same identifier for each patient regardless of his journey.
- Hashing. Patient identifiers are combined with the token and processed through a secure hash (like SHA-256) to create the pseudo-identifier.
- Storage. The pseudo-identifier is stored with the patient’s data and used to aggregate data across different locations.
- Non-Reversibility. Strong cryptography ensures the identifier can’t be reverse engineered, with extra security through secure token management.
- Additional Security. Extra measures like isolated environments, strict access control, and continuous monitoring ensure data security and privacy.
Advantages and Benefits
Enhanced Privacy and Security
- Patients’ personal data is protected through the use of non-reversible pseudo-identifiers.
- Strong cryptographic methods and secure salt management ensure data remains confidential.
Improved Data Management
- Consistent identifiers across sites facilitate the accurate and efficient combination of single patient data.
- Eliminates data silos and enhances collaboration among different healthcare providers involved in the trial.
Regulatory Compliance
- Adheres to data protection regulations such as GDPR and HIPAA.
- Regular updates and security audits ensure ongoing compliance with evolving standards.
Operational Efficiency
- Streamlines the process of managing patient identifiers across different systems.
- Reduces administrative burden and complexity, saving time and resources.
Scalability
- Easily accommodates the addition of new sites and an increasing number of patients without significant changes.
- Handles large volumes of patient data efficiently, supporting extensive clinical trials.
Patient Trust
- Builds confidence among patients by demonstrating robust data privacy and security practices.
- Assures patients that their personal information is managed securely and responsibly.
All Our Services
GenAI-Driven Synthetic Control Arm
GenAI-Driven RWD Acquisition & Analysis
Target Trial Emulation for Drug Repurposing
Realistic and Privacy-guarantees Synthetic Patient Data
Clinical Trial Simulation in Silico
Patient’s Data De-Identifier
GenAI-Driven Remote Verbal Consent
CONTACT DETAILS
info@aimedtrial.com
+39 3482630229